Uric acid and unhealthy metabolic phenotype in Colombian children

Gina Gonzalez-Valencia; Johana Hernandez; Silvia Rueda; Nora Espinosa; Adriana Forero; Jose Balmaceda; Juan Gualdron; Juan Gaviria; Maria Montilla; Juan Velasquez

doi:10.5114/pedm.2025.158545

eISSN: 2083-8441
ISSN: 2081-237X

Pediatric Endocrinology Diabetes and Metabolism

Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury

Panel Redakcyjny

Zgłaszanie i recenzowanie prac online

Wyszukiwanie

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Otwarty dostęp

Zintegrowane z publons

4/2025
vol. 31

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

Artykuł oryginalny

Kwas moczowy i niezdrowy fenotyp metaboliczny u kolumbijskich dzieci

Gina Marcela Gonzalez-Valencia

¹

,

Johana Botero Hernandez

¹

,

Silvia Martinez Rueda

¹

,

Nora Alejandra Zuluaga Espinosa

^{1, 2}

,

Adriana Carolina Forero

^{1, 2}

,

Jose Leonardo Balmaceda

³

,

Juan Pablo Gualdron

³

,

Juan Jose Gaviria

⁴

,

Maria del Pilar Montilla

¹

,

Juan Manuel Alfaro Velasquez

¹

Department of Pediatric Endocrinology, School of Medicine, University of Antioquia, Medellín, Colombia
Hospital Universitario San Vicente Fundación, Medellín, Colombia
Department of Pediatrics, Hospital Concejo de Medellín, Colombia
Department of Telemedicine, University of Antioquia, Medellín, Colombia

Pediatr Endocrinol Diabetes Metab 2025; 31 (4): 169-175

DOI: https://doi.org/10.5114/pedm.2025.158545

Data publikacji online: 2026/01/27

Pliki artykułu:

- 0394_Uric acid.pdf [0.83 MB]

- 0394_Supplementary Table 1.pdf [0.19 MB]

Pobierz cytowanie

Metryki PlumX:

1. World Health Organization. Taking Action on Childhood Obesity. WHO, Geneva 2018; 1–8.

2. Obesidad y sobrepeso [Internet]. Available at: https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight.

3. Sims EA. Are there persons who are obese, but metabolically healthy?. Metabolism. 2001; 50: 1499–1504. doi: 10.1053/meta.

4. 2001.27213.

5. Iacobellis G, Ribaudo MC, Zappaterreno A, et al. Prevalence of uncomplicated obesity in an Italian obese population. Obes Res 2005; 13: 1116–1122. doi: 10.1038/oby.2005.130.

6. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008; 168: 1617–1624. doi: 10.1001/archinte.168.15.1617.

7. Abiri B, Valizadeh M, Amini S, et al. Risk factors, cutoff points, and definition of metabolically healthy/unhealthy obesity in children and adolescents: A scoping review of the literature. Obes Rev 2023; 24: e13548. doi: 10.1111/obr.13548.

8. Díaz-Ortega JL, Yupari-Azabache IL, Caballero Vidal JA, et al. Criteria in the Diagnosis of Metabolic Syndrome in Children: A Scoping Review. Diabetes Metab Syndr Obes 2023; 16: 3489–3500. doi: 10.2147/DMSO.S430360.

9. Zong X, Bovet P, Xi B. A Proposal to Unify the Definition of the Metabolic Syndrome in Children and Adolescents. Front Endocrinol (Lausanne) 2022; 13: 925976. doi: 10.3389/fendo.2022.925976.

10. Codazzi V, Frontino G, Galimberti L, et al. Mechanisms and risk factors of metabolic syndrome in children and adolescents. Endocrine 2024; 84: 16–28. doi: 10.1007/s12020-023-03642-x.

11. Damanhoury S, Newton AS, Rashid M, et al. Defining metabolically healthy obesity in children: a scoping review. Obes Rev 2018; 19: 1476–1491. doi: 10.1111/obr.12721.

12. Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. Int J Mol Sci 2021; 22: 9221. doi: 10.3390/ijms22179221.

13. Jensen T, Abdelmalek MF, Sullivan S, et al. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J Hepatol 2018; 68: 1063–1075. doi: 10.1016/j.jhep.2018.01.019.

14. Yu W, Cheng JD. Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective. Front Pharmacol 2020; 11: 582680. doi: 10.3389/fphar.2020.582680.

15. Mangge H, Zelzer S, Puerstner P, et al. Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults. Obesity (Silver Spring) 2013; 21: E71-E77. doi: 10.1002/oby.20061.

16. Kubota M. Hyperuricemia in Children and Adolescents: Present Knowledge and Future Directions. J Nutr Metab 2019; 2019: 3480718. doi: 10.1155/2019/3480718.

17. Fernández JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004; 145: 439–444. doi: 10.1016/j.jpeds.2004.06.044.

18. Moulin-Mares SRA, Zaniqueli D, Oliosa PR, et al. Uric acid reference values: report on 1750 healthy Brazilian children and adolescents. Pediatr Res 2021; 89: 1855-1860. doi:10.1038/s41390-020-01185-9.

19. Xi B, Zong X, Kelishadi R, et al. International Waist Circumference Percentile Cutoffs for Central Obesity in Children and Adolescents Aged 6 to 18 Years. J Clin Endocrinol Metab 2020; 105: e1569–e1583. doi: 10.1210/clinem/dgz195.

20. Nur Zati Iwani AK, Jalaludin MY, Wan Mohd Zin RM, et al. TG : HDL-C Ratio Is a Good Marker to Identify Children Affected by Obesity with Increased Cardiometabolic Risk and Insulin Resistance. Int J Endocrinol 2019; 2019: 8586167. doi: 10.1155/2019/8586167.

21. Che B, Zhong C, Zhang R, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol 2023; 22: 34. doi: 10.1186/s12933-023-01762-2.

22. Wan Mohd Zin RM, Jalaludin MY, Yahya A, et al. Prevalence and clinical characteristics of metabolically healthy obese versus metabolically unhealthy obese school children. Front Endocrinol (Lausanne) 2022; 13: 971202. doi: 10.3389/fendo.2022.971202.

23. Genovesi S, Antolini L, Orlando A, et al. Cardiovascular Risk Factors Associated With the Metabolically Healthy Obese (MHO) Phenotype Compared to the Metabolically Unhealthy Obese (MUO) Phenotype in Children. Front Endocrinol (Lausanne) 2020; 11: 27. doi: 10.3389/fendo.2020.00027.

24. Kurnaz E, Türkyilmaz A, Çayir A. Can Uric Acid Be A Marker For Metabolically Unhealthy Obesity in Children and Adolescents? Turk J Pediatr Dis 2021; 15: 226–233.

25. Rocha EPAA, Vogel M, Stanik J, et al. Serum Uric Acid Levels as an Indicator for Metabolically Unhealthy Obesity in Children and Adolescents. Horm Res Paediatr 2018; 90: 19-27. doi: 10.1159/000490113.

26. Remor JM, Lopes WA, Locateli JC, et al. Prevalence of metabolically healthy obese phenotype and associated factors in South American overweight adolescents: A cross-sectional study. Nutrition 2019; 60: 19–24. doi: 10.1016/j.nut.2018.08.017.

27. Di Bonito P, Pacifico L, Chiesa C, et al. Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity. J Endocrinol Invest 2017; 40: 409–416. doi: 10.1007/s40618-016-0576-8.

28. Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res 2006; 60: 759–763. doi: 10.1203/01.pdr.0000246097.73031.27.

29. Nur Zati Iwani AK, Jalaludin MY, Yahya A, et al. TG: HDL-C Ratio as Insulin Resistance Marker for Metabolic Syndrome in Children With Obesity. Front Endocrinol (Lausanne) 2022; 13: 852290. doi: 10.3389/fendo.2022.852290.

30. Reckziegel MB, Nepomuceno P, Machado T, et al. The triglyceride-glucose index as an indicator of insulin resistance and cardiometabolic risk in Brazilian adolescents. Arch Endocrinol Metab 2023; 67: 153–161. doi: 10.20945/2359-3997000000506.

31. Locateli JC, Lopes WA, Simões CF, et al. Triglyceride/glucose index is a reliable alternative marker for insulin resistance in South American overweight and obese children and adolescents. J Pediatr Endocrinol Metab 2019; 32: 1163–1170. doi: 10.1515/jpem-2019-0037.

Kwas moczowy i niezdrowy fenotyp metaboliczny u kolumbijskich dzieci

Gina Marcela Gonzalez-Valencia 1 , Johana Botero Hernandez 1 , Silvia Martinez Rueda 1 , Nora Alejandra Zuluaga Espinosa 1, 2 , Adriana Carolina Forero 1, 2 , Jose Leonardo Balmaceda 3 , Juan Pablo Gualdron 3 , Juan Jose Gaviria 4 , Maria del Pilar Montilla 1 , Juan Manuel Alfaro Velasquez 1